Colloidal oatmeal 1% is efficacious in treating mild-to-moderate AD in Black children, according to a recent study.

Dr. Ronald B. Vender gives insights into JAK inhibitors and patient aspects of skin diseases at the 2023 EADV Congress in Berlin.

Dr. Ronald B. Vender recaps the most popular presentations at the 2023 EADV Congress in Berlin.

Dr. Fiona Lovegrove reports on a late breaking presentation about the efficacy and safety of abrocitinib at the 2023 EADV Congress in Berlin

Dr. Fiona Lovegrove reports on the late breaking presentation on rezpegaldesleukin at the 2023 EADV Congress in Berlin.

Dr. Fiona Lovegrove reports on bullous diseases at the 2023 EADV Congress in Berlin.

Dr. Vimal Prajapati reports on common molecular signatures of chronic hand eczema at the 2023 EADV Congress in Berlin.

Dr. Vimal Prajapati reports about tapinarof 1% cream for treating severe AD at the 2023 EADV Congress in Berlin.